The Global Chemotherapy Devices Market, by Product (Catheter, Cannula, Pump, and Others), by End User (Hospitals, Clinics, and Home Care), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 10.9 billion in 2017, and is projected to exhibit a CAGR of 7.7% over the forecast period (2018 - 2026).

Technological advancements in cancer treatments such as chemotherapy and rising investment in cancer care are reducing the number of cancer deaths worldwide. According to the Cancer Journal for Clinicians 2016 study, the number of cancer survivors continues to grow in the U.S. due to increasing number of new cancer diagnoses resulting from a growing and aging population. As per the same report, over 15.5 million Americans with a history of cancer were alive on January 1, 2016 and this number is projected to reach 20.3 million by January 1, 2026. Chemotherapy is most often administrated via a vein (intravenously) using devices such as catheter and ports. Long-term central venous access devices are essential for the management of cancer patients, as they minimize the discomfort of frequent venipuncture and cannulation. A catheter reduce the number of times to insert a needle in patient vein. According to the WHO 2017 report, in most upper and middle income countries, the chemotherapy dosage for some treatments and for patients with metastatic diseases is done using implantable central venous catheters or peripherally inserted central catheters (PICC).

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2231

Manufacturers in the chemotherapy devices market are focused on technological advancements in devices. For instance, in May 2018, Advanced Chemotherapy Technologies announced development of an implant, about the size of a large coin for direct delivery of chemo agents into the pancreas. In 2017, RenovoRx received FDA approval for RenovoCath dual-balloon infusion catheter to include the delivery of chemotherapeutics. Browse 24 Market Data Tables and 25 Figures spread through 170 Pages and in-depth TOC on "Chemotherapy Devices Market, by Product (Catheter, Cannula, Pump, and Others), by End User (Hospitals, Clinics, and Home Care), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/chemotherapy-devices-market-2231

Key Takeaways of the Chemotherapy Devices Market:

The global chemotherapy devices market is expected to expand at a CAGR of 7.7% during the forecast period (2018–2026), owing to rising cancer incidence coupled with increasing consumption of tobacco and alcohol, and rising geriatric population base

Among product, the pumps segment is expected to generate significant revenue in 2018, due to high price as compared to other products.

Major players operating in the global chemotherapy devices market include Advanced Chemotherapy Technologies, Baxter International, Becton, Dickinson Company, B. Braun, Fresenius Kabi, Halyard Health, ICU Medical, Moog Inc., Micrel Medical, Smiths Group, Terumo Corporation, and Zyno Medical

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2231

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737